A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy.

[1]  W. Travis.  Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas , 2012, Modern Pathology.

[2]  E. Brambilla,et al.  Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis , 2008, European Respiratory Journal.

[3]  Takehiko Fujisawa,et al.  Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis , 2006, Modern Pathology.

[4]  Y. Ishikawa,et al.  Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis , 2005, Virchows Archiv.

[5]  Kenji Suzuki,et al.  Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). , 2005, The Journal of thoracic and cardiovascular surgery.

[6]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[7]  Carl Virtanen,et al.  Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles , 2004, The Lancet.

[8]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[9]  P. Lamy,et al.  Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. , 2003, Lung cancer.

[10]  M. Sheppard,et al.  Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens , 2002, The American journal of surgical pathology.

[11]  E. Brambilla,et al.  Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. , 2001, Human pathology.

[12]  H. Wada,et al.  Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1‐cell adhesion molecule) on resected small cell lung cancer specimens: In relation to proliferation state , 2001, Journal of surgical oncology.

[13]  M. Bongiovanni,et al.  34βE 12 Cytokeratin Immunodetection in the Differential Diagnosis of Small Cell Tumors of Lung , 2000, International journal of surgical pathology.

[14]  P. Lamy,et al.  Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. , 2000, Lung cancer.

[15]  J. Daurès,et al.  Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent , 2000, British Journal of Cancer.

[16]  A. Elias.  Small cell lung cancer: state-of-the-art therapy in 1996. , 1997, Chest.

[17]  D. Ihde.  Small Cell Lung Cancer: State-of-the-Art Therapy 1994 , 1995 .

[18]  G. Jaques,et al.  Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer , 1993, Cancer.

[19]  J P Pignon,et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.

[20]  H. Wisniewski,et al.  IMMUNOSUPPRESSION BY LINOLEIC ACID , 1975, The Lancet.

[21]  A. Miller,et al.  Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. , 1969, Lancet.

[22]  R. A. Green,et al.  Alkylating agents in bronchogenic carcinoma. , 1969, The American journal of medicine.

[23]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[24]  Hisao Asamura,et al.  Neuroendocrine neoplasms of the lung: a prognostic spectrum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[26]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.